Log in or register
Share on LinkedInShare on LinkedIn

ARTICLE · 28 SEPTEMBER 2021

NYS Cannabis Industry Takes Big Step Forward With Final Cannabis Control Board Appointments

Lippes Mathias LLP
Explore more from Lippes Mathias LLP

In a critical step forward for New York State's cannabis industry, on Thursday, September 23, 2021, Governor Kathy Hochul appointed Jessica Garcia and Reuben McDaniel III to the state's Cannabis Control Board (CCB).

United StatesCannabis & Hemp
Joseph W. Schafer
Joseph W. Schafer

In a critical step forward for New York State's cannabis industry, on Thursday, September 23, 2021, Governor Kathy Hochul appointed Jessica Garcia and Reuben McDaniel III to the state's Cannabis Control Board (CCB).  Garcia and McDaniel III join Adam W. Perry, Jen Metzger, and Board Chair Tremaine Wright to make up the five-member board responsible for devising the framework of the State's newly legalized adult-use cannabis industry.  These two appointments ended an almost six-month delay in the development of the state's adult-use cannabis market, which will begin to take shape in the coming months.

Significant concern arose in June 2021 when New York State's legislative session ended and no appointments to the CCB or the newly established Office of Cannabis Management (OCM) had been made.  Absent a special session, the next time the State Legislature was slated to convene was January 2022, delaying the anticipated opening of the state's legal cannabis industry for

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

Register for freeORLog in

View source

Related Articles

Legal Intelligence Newsletters: sign up for the latest legal and regulatory news on your chosen topics

Read more about

See more popular content from

Article

The Intoxicating Hemp Products Ban Was Delayed A Month. Now What?

The House has passed a short-term funding bill postponing the federal ban on hemp-derived THC products from November 12th to December 11th. With comprehensive legislation unlikely before the new deadline and competing interests from cannabis sellers, alcohol producers, and state regulators creating policy gridlock, the future of intoxicating hemp products remains uncertain as midterm elections approach.
United StatesCannabis & Hemp
Harris Sliwoski
Harris Sliwoski
Article

"Marijuana" Rescheduling Delayed, Again. What It Could Mean, And What Comes Next

The DEA's marijuana rescheduling hearing has been unexpectedly stayed following a motion to admit a new GAO report examining agency scheduling procedures. With the proceeding on hold and the medical marijuana Schedule III order facing legal challenges in the D.C. Circuit, the cannabis industry's path to federal tax relief through rescheduling has become increasingly uncertain.
United StatesCannabis & Hemp
Harris Sliwoski
Harris Sliwoski
Article

IRC Section 280E And Cannabis Tax Planning: Recent Developments And Practical Considerations

The landscape surrounding Section 280E of the Internal Revenue Code continues to evolve with President Trump's Executive Order on medical marijuana rescheduling, advancing litigation in New Mexico Top Organics v. Commissioner, and shifting regulatory signals. Cannabis taxpayers face critical decisions about taking "non-280E" positions on their tax returns while the IRS maintains its enforcement stance and the U.S. Tax Court case addressing common arguments remains pending.
United StatesCannabis & Hemp
Foley Hoag LLP
Foley Hoag LLP